Molecular biology

Adverum Biotechnologies to Participate in Goldman Sachs 41st Annual Global Healthcare Conference

Thursday, June 4, 2020 - 9:05pm

REDWOOD CITY, Calif., June 04, 2020 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that the company will present at the Goldman Sachs 41st Annual Global Healthcare Conference on Thursday, June 11, 2020 at 3:50 pm EDT.

Key Points: 
  • REDWOOD CITY, Calif., June 04, 2020 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that the company will present at the Goldman Sachs 41st Annual Global Healthcare Conference on Thursday, June 11, 2020 at 3:50 pm EDT.
  • A live webcast will be accessible under Events and Presentations in the Investors section of the companys website.
  • The archived webcast will be available on the Adverum website following the presentation for 30 days.
  • Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs in serious ocular and rare diseases.

Kansas Sheriff's Office Now Using STRmix

Thursday, June 4, 2020 - 2:30pm

The Johnson County Sheriff's Office Criminalistics Laboratory aids in criminal investigations through timely, unbiased, high-quality forensic services performed by highly trained experts using state-of the art instrumentation and scientific techniques.

Key Points: 
  • The Johnson County Sheriff's Office Criminalistics Laboratory aids in criminal investigations through timely, unbiased, high-quality forensic services performed by highly trained experts using state-of the art instrumentation and scientific techniques.
  • Fifty-six forensic labs nationally are now using STRmix to interpret DNA profiles in criminal investigations.
  • Four other labs the Wisconsin State Crime Laboratories, the Jefferson Parish (LA) Sheriff's Office Regional DNA Laboratory, the Contra Costa County (CA) Office of the Sheriff, and New York's Suffolk County Crime Laboratory began using STRmix earlier this year.
  • The latest version of STRmix, STRmix v2.7, was introduced in late 2019.

FDA Approves Elixirgen Therapeutics IND Application for Therapy for Telomere Biology Disorders with Bone Marrow Failure

Thursday, June 4, 2020 - 2:07pm

EXG34217 is an autologous cell therapy for telomere biology disorders with bone marrow failure.

Key Points: 
  • EXG34217 is an autologous cell therapy for telomere biology disorders with bone marrow failure.
  • This program's treatment paradigm uses Elixirgen Therapeutics' proprietary ZSCAN4 technology to extend the telomeres of the hematopoietic stem cells of the patients.
  • For more information visit https://ElixirgenTherapeutics.com
    This press release may contain "forward-looking" statements, including statements regarding the effectiveness of EXG34217 to treat telomere biology disorders with bone marrow failure and statements relating to the planned clinical trials of EXG34217.
  • Actual results may differ materially from those set forth in this press release due to the risks and uncertainties inherent in drug research and development.

Qualigen Therapeutics Receives U.S. Patent Notice of Allowance for its STARS™ Technology

Thursday, June 4, 2020 - 1:00pm

STARS is a DNA/RNA-based treatment for the removal of viral and tumor-produced compounds from a patient's blood.

Key Points: 
  • STARS is a DNA/RNA-based treatment for the removal of viral and tumor-produced compounds from a patient's blood.
  • "When issued, this new U.S. patent will further protect our proprietary STARS technology and enhance our overall intellectual property portfolio," said Michael Poirier, President, Chief Executive Officer and Chairman of Qualigen.
  • We look forward to advancing STARS as a target and removal therapy for multiple diseases and other health conditions."
  • For more information on Qualigen Therapeutics, Inc. or to order FastPack diagnostic products, please visit https://www.qualigeninc.com/ .

InsightMonk Launches Top 25 Voices Awards in Healthcare Robotics & Precision Medicine Asia

Thursday, June 4, 2020 - 11:30am

It enabled us to identify healthcare robotics and precision medicine in Asia as two transformative themes and enablers of the future of healthcare delivery."

Key Points: 
  • It enabled us to identify healthcare robotics and precision medicine in Asia as two transformative themes and enablers of the future of healthcare delivery."
  • Healthcare robotics initiated one of the pivotal paradigm shifts witnessed by the global healthcare industry in the 20th century.
  • On the other hand, Asia is emerging as the next hub for precision medicine, with improving research competency in genome sequencing and increased government funding.
  • Click here to nominate in Healthcare Robotics or Precision Medicine Asia .

InsightMonk Launches Top 25 Voices Awards in Healthcare Robotics & Precision Medicine Asia

Thursday, June 4, 2020 - 11:30am

It enabled us to identify healthcare robotics and precision medicine in Asia as two transformative themes and enablers of the future of healthcare delivery."

Key Points: 
  • It enabled us to identify healthcare robotics and precision medicine in Asia as two transformative themes and enablers of the future of healthcare delivery."
  • Healthcare robotics initiated one of the pivotal paradigm shifts witnessed by the global healthcare industry in the 20th century.
  • On the other hand, Asia is emerging as the next hub for precision medicine, with improving research competency in genome sequencing and increased government funding.
  • Click here to nominate in Healthcare Robotics or Precision Medicine Asia .

Murrieta Genomics Subsidiary SimplSeq Files for Third Patent Designed to Improve DNA and RNA Sample Preparation

Thursday, June 4, 2020 - 11:00am

MURRIETA, Calif., June 4, 2020 /PRNewswire-PRWeb/ -- Murrieta Genomics has announced that its wholly owned subsidiary, SimplSeq Inc. , has filed a new patent application for simplified sample preparation for Next Generation Genomic Sequencing (NGS) .

Key Points: 
  • MURRIETA, Calif., June 4, 2020 /PRNewswire-PRWeb/ -- Murrieta Genomics has announced that its wholly owned subsidiary, SimplSeq Inc. , has filed a new patent application for simplified sample preparation for Next Generation Genomic Sequencing (NGS) .
  • This is the third application filed by SimplSeq around technology that will greatly reduce cost, time, and complexity of sample preparation.
  • "In many cases, all of the original DNA or RNA is consumed in the sample preparation and sequencing process.
  • "This is exactly the type of innovation and impact Murrieta Genomics was founded for," stated Jay Goth, CEO of Murrieta Genomics.

Transfection Reagents and Equipment Market 2020-2024 | Need for Timely Disease Diagnosis to Boost Growth | Technavio

Wednesday, June 3, 2020 - 9:30pm

The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Key Points: 
  • The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
  • Market estimates include pre- and post-COVID-19 impact on the Transfection Reagents and Equipment Market Download free sample report
    The market is fragmented, and the degree of fragmentation will accelerate during the forecast period.
  • The need for timely disease diagnosis has been instrumental in driving the growth of the market.
  • https://www.technavio.com/report/global-transfection-reagents-and-equipm...
    Transfection Reagents and Equipment Market 2020-2024: Segmentation
    Transfection Reagents and Equipment Market is segmented as below:

Datametrex Reports Government Clearance To Fulfill Its First COVID-19 Test Kit Order

Wednesday, June 3, 2020 - 7:09pm

Each kit contains 288 individual tests, all of which can be completed in one hour.

Key Points: 
  • Each kit contains 288 individual tests, all of which can be completed in one hour.
  • The Company has secured all testing kits, swabs, tubes and the PCR machine from the manufacturer required to fulfill the order.
  • Datametrex anticipates that it will have little or no upfront costs associated with the sale of these test kits.
  • Security clearance backlogs continue to streamline as Governments align with the World Health Organizations remarks on the importance of testing.

Nucleic Acid Isolation and Purification Market Worth $4.8 Billion by 2025 - Exclusive Report by MarketsandMarkets™

Wednesday, June 3, 2020 - 3:30pm

On the basis of application, the global nucleic acid isolation and purification market is segmented into diagnostics, drug discovery & development, personalized medicine, agriculture & animal research, and other applications.

Key Points: 
  • On the basis of application, the global nucleic acid isolation and purification market is segmented into diagnostics, drug discovery & development, personalized medicine, agriculture & animal research, and other applications.
  • On the basis of type, the global nucleic acid isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation and purification, circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR cleanup, and other nucleic acid isolation and purification types.
  • Get 10% Customization on this Research Report:
    North America dominates the nucleic acid isolation and purification market during the forecast period.
  • In 2019, North America accounted for the largest share of the nucleic acid isolation and purification market, followed by Europe.